Tandem Diabetes Care (TNDM) Free Cash Flow (2013 - 2026)

Tandem Diabetes Care's Free Cash Flow history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• Quarterly Free Cash Flow rose 122.53% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 124.13% YoY) and the FY2025 annual result came in at -$29.7 million, down 218.12% from the prior year.
• Free Cash Flow was $4.8 million for Q1 2026 at Tandem Diabetes Care, up from $3.1 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $27.8 million in Q4 2024 and bottomed at -$27.2 million in Q1 2023.
• A 5-year average of $866823.5 and a median of $3.1 million in 2025 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 319.97% — and 2024, when it jumped 410.44%.
• Tandem Diabetes Care's Free Cash Flow stood at $5.6 million in 2022, then slumped by 260.52% to -$8.9 million in 2023, then soared by 410.44% to $27.8 million in 2024, then tumbled by 88.82% to $3.1 million in 2025, then soared by 54.19% to $4.8 million in 2026.
• Business Quant data shows TNDM's Free Cash Flow at $4.8 million in Q1 2026, $3.1 million in Q4 2025, and -$3.9 million in Q3 2025.